Zortress Related Clinical Trials
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer [Recruiting]
Phase I/Ib Dose Escalation & Biomarker Study of Ceritinib (LDK378) + Everolimus for Locally Advanced or Metastatic Solid Tumors With an Expansion in Non-Small Cell Lung Cancer (NSCLC) Characterized by Abnormalities in Anaplastic Lymphoma Kinase (ALK) Expression [Not yet recruiting]
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) [Completed]
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease [Withdrawn]
Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab [Recruiting]
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects [Completed]
Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma [Terminated]
Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients [Completed]
Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients [Withdrawn]
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas [Terminated]
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib [Completed]
STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma [Recruiting]
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer [Recruiting]
Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma [Recruiting]
Comparing Everolimus and Sirolimus in Renal Transplant Recipients [Active, not recruiting]
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients [Recruiting]
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer [Active, not recruiting]
Sirolimus for Autoimmune Disease of Blood Cells [Recruiting]
Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC [Terminated]
Study of RAD001 (Everolimus) for Children With NF1 and Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas [Active, not recruiting]
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer [Completed]
Topical Rapamycin to Erase Angiofibromas in TSC [Completed]
Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients [Completed]
Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) [Active, not recruiting]
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Terminated]
LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma [Recruiting]
Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma [Withdrawn]
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer [Withdrawn]
Study of Suberoylanilide Hydroxamic Acid (SAHA) With Temsirolimus in Children With Diffuse Intrinsic Pontine Glioma (DIPG) [Not yet recruiting]
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET [Completed]
Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients [Recruiting]
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients [Completed]
Pharmacokinetic of Everolimus and Atorvastatin Co-administration [Completed]
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer [Completed]
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI [Recruiting]
Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects [Completed]
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients [Active, not recruiting]
Safety of Everolimus and Pemetrexed in Lung Cancer Patients [Completed]
Phase II Study of Intrauterine Device (IUD) Alone or in Combination With Everolimus in Endometrial Cancer [Not yet recruiting]
Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma [Recruiting]
Dose Finding Study of RAD001 (Everolimus, Afinitor�) in Combination With BEZ235 in Patients With Advanced Solid Tumors [Completed]
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas [Recruiting]
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer [Completed]
Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection [Completed]
Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia [Active, not recruiting]
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS) [Recruiting]
Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Active, not recruiting]
Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV) [Completed]
Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]
A Trial of Dasatinib (PDGFR and SRC Inhibitor), Temsirolimus and Cyclophosphamide in Patients With Advanced Solid Tumors [Not yet recruiting]
Rapamycin and Regulatory T Cells in Kidney Transplantation [Completed]
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Recruiting]
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Active, not recruiting]
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer [Active, not recruiting]
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer [Recruiting]
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers [Recruiting]
A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma [Completed]
Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer [Active, not recruiting]
Vandetanib With Everolimus [Recruiting]
Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas [Completed]
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis [Recruiting]
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma [Completed]
RAD001 and Erlotinib in Patients With Neuroendocrine Tumors [Active, not recruiting]
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study [Recruiting]
Pharmacokinectics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity [Terminated]
RAD001 in Advanced Hepatocellular Carcinoma [Completed]
Influence of Exceptional Patient Characteristics on Everolimus Exposure [Recruiting]
Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors [Completed]
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors [Active, not recruiting]
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) [Recruiting]
Study of Temsirolimus, Topotecan, and Bortezomib [Completed]
A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys [Recruiting]
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors [Completed]
A Study of RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic Squamous Cell Cancer of the Head and Neck [Terminated]
Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma [Recruiting]
Everolimus for Children With Recurrent or Progressive Ependymoma [Recruiting]
Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer [Active, not recruiting]
Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients [Active, not recruiting]
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors [Completed]
Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers [Active, not recruiting]
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. [Completed]
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) [Active, not recruiting]
Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients [Active, not recruiting]
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer [Completed]
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias [Completed]
Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer [Recruiting]
Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma [Completed]
The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas [Active, not recruiting]
Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up [Completed]
SORAVE - Sorafenib and Everolimus in Solid Tumors [Recruiting]
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas [Recruiting]
Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma [Recruiting]
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) [Completed]
RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer [Completed]
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer [Terminated]
Rapamycin Plus Bevacizumab in Advanced Cancers [Completed]
Rapamycin in Relapsed Acute Lymphoblastic Leukemia [Active, not recruiting]
|